Laila Khazai, MD

Dr. Khazai earned her medical degree at the Mashhad University of Medical Sciences in Iran, followed by a residency in surgical pathology at Vanderbilt University Medical School. She then completed two fellowships: one in cytopathology and another in breast pathology, both at the University of Texas MD Anderson Cancer Center. She is board certified in cytopathology.

Provider

Laila Khazai, MD

Pathology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Anatomic Pathology

Print Print Physician Bio

Education & Training

BOARD CERTIFICATION:
  • Cytopathology
  • Anatomic Pathology
FELLOWSHIP:
  • University of Texas MD Anderson Cancer Center - Cytopathology
  • University of Texas MD Anderson Cancer Center - Breast Pathology
RESIDENCY:
  • Vanderbilt University Medical School - Surgical Pathology
MEDICAL SCHOOL:
  • Mashad University of Medical Sciences - MD
Provider

Laila Khazai, MD

Pathology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Anatomic Pathology

Print Print Physician Bio

Publications

  • Khazai L, Agosto-Arroyo E, Rosa M. P40 Immunostain Does Not Outperform p63 as a Myoepithelial Cell Marker in the Daily Practice of Breast Pathology. Appl Immunohistochem Mol Morphol. 2017 May. Pubmedid: 28549030.
  • Valderrabano P, Khazai L, Leon ME, Thompson ZJ, Ma Z, Chung CH, Hallanger-Johnson JE, Otto KJ, Rogers KD, Centeno B, McIver B. Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology. Endocr Relat Cancer. 2017 Mar;24(3):127-136. Pubmedid: 28104680.
  • Agosto-Arroyo E, Rosa M, Chau A, Khazai L. Concurrent BRAF and PTEN mutations in melanoma of unknown origin presenting as a breast mass. SAGE Open Med Case Rep. 2017;5:2050313X17711064. Pubmedid: 28607685. Pmcid: PMC5456025.
  • Valderrabano P, Montilla Soler J, Mifsud MJ, Leon ME, Centeno BA, Khazai L, Padhya T, McCaffrey TV, Russell JS, McIver B, Otto KJ. Hypermetabolism on (18)F-Fluorodeoxyglucose Positron Emission Tomography Scan Does Not Influence the Interpretation of Thyroid Cytopathology, and Nodules with a SUVmax <2.5 Are Not at Increased Risk for Malignancy. Thyroid. 2016 Sep;26(9):1300-1307. Pubmedid: 27324615.
  • Valderrabano P, Leon ME, Centeno BA, Otto KJ, Khazai L, McCaffrey JC, Russell JS, McIver B. Institutional prevalence of malignancy of indeterminate thyroid cytology is necessary but insufficient to accurately interpret molecular marker tests. Eur J Endocrinol. 2016 May;174(5):621-629. Pubmedid: 26903551.
  • Khazai L, Falcon S, Rosa M. Metastatic Salivary Duct Carcinoma to the Breast. Breast J. 2016 Jul;22(4):461-463. Pubmedid: 27089239.
  • Khazai L, Chau A, Hoover S, Rosa M. Papillary endothelial hyperplasia arising in the irradiated breast: A diagnostic dilemma. Pathol Res Pract. 2016 Jul;212(7):604-607. Pubmedid: 27157404.
  • Khazai L, Middleton LP, Goktepe N, Liu BT, Sahin AA. Breast pathology second review identifies clinically significant discrepancies in over 10% of patients. J Surg Oncol. 2015 Feb;111(2):192-197. Pubmedid: 25273328.
  • Patel BK, Jafarian N, Abbott AM, Khazai L, Lee MC. Imaging Findings and Management of Primary Breast Cancer in Accessory Axillary Breast Tissue. Clin Breast Cancer. 2015 Aug;15(4):e223-e229. Pubmedid: 25986957.
  • Khazai L, Rosa M. Use of Immunohistochemical Stains in Epithelial Lesions of the Breast. Cancer Control. 2015 Apr;22(2):220-225. Pubmedid: 26068768.
  • Khazai L, Kundu UR, Jacob B, Patel S, Sneige N, Eapen GA, Morice RC, Caraway NP. Endobronchial ultrasound-guided transbronchial needle aspiration biopsy is useful evaluating mediastinal lymphadenopathy in a cancer center. Cytojournal. 2011 Jul;8:10. Pubmedid: 21712956. Pmcid: PMC3120041.
  • Resetkova E, Khazai L, Albarracin CT, Arribas E. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast. Breast J. 2010 Nov;16(6):573-580. Pubmedid: 21070433.
  • Dimashkieh HH, Khazai L, Novak GD, Casey MB. Pathologic quiz case: an 83-year-old woman with a uterine cervical mass. Adenoid cystic carcinoma. Arch Pathol Lab Med. 2004 Jul;128(7):817-818. Pubmedid: 15214839.

Provider

Laila Khazai, MD

Pathology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Anatomic Pathology

Print Print Physician Bio

Participating Trials

CLINICAL TRIAL 18936
A Phase I-II Study of Interferon-gamma Plus Weekly Paclitaxel, Trastuzumab and Pertuzumab in Patients with HER-2 Positive Breast Cancer
Condition: Breast
Intervention: Herceptin (Trastuzumab); Pertuzumab; Taxol (paclitaxel); Trastuzumab; interferon gamma (Actimmune); paclitaxel; rhuMAb HER2 (Trastuzumab)
Open

If you believe you are eligible for one of these trials or studies, please call
1-888-MOFFITT (1-888-663-3488).


Provider

Laila Khazai, MD

Pathology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Anatomic Pathology

Print Print Physician Bio